Efficacy and safety of RGB-02, a pegfilgrastim biosimilar to prevent chemotherapy-induced neutropenia: results of a randomized, double-blind phase III clinical study vs. reference pegfilgrastim in patients with breast cancer receiving chemotherapy

Kahán Zsuzsanna, Grecea Daniela, Smakal Martin, Tjulandin Sergei, Bondarenko Igor, Perjesi Luca, Illes Andras, Horvat-Karaj Karoly, Aradi Ildikó: Efficacy and safety of RGB-02, a pegfilgrastim biosimilar to prevent chemotherapy-induced neutropenia: results of a randomized, double-blind phase III clinical study vs. reference pegfilgrastim in patients with breast cancer receiving chemotherapy.
BMC CANCER, 19 (1). pp. 2-10. ISSN 1471-2407 (2019)

[img]
Preview
Text
document4.pdf - Published Version

Download (831kB) | Preview
Item Type: Article
Journal or Publication Title: BMC CANCER
Date: 2019
Volume: 19
Number: 1
Page Range: pp. 2-10
ISSN: 1471-2407
Faculty: Általános Orvostudományi Kar
Institution: Szegedi Tudományegyetem
SWORD language: Angol
Identification Number: 30617312
DOI id: https://doi.org/10.1186/s12885-019-5329-6
Date Deposited: 2019. Apr. 03. 09:18
Last Modified: 2019. Apr. 03. 09:18
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/15013

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year